Open Access

CEP131 knockdown inhibits cell proliferation by inhibiting the ERK and AKT signaling pathways in non‑small cell lung cancer

  • Authors:
    • Junying Wang
    • Xiaoping Yang
    • Shixin Han
    • Lizhi Zhang
  • View Affiliations

  • Published online on: February 19, 2020     https://doi.org/10.3892/ol.2020.11411
  • Pages: 3145-3152
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Disrupted centrosome‑associated family protein expression can result in the detrimental duplication of centrosomes, causing genomic instability and subsequent carcinogenesis. Limited research has demonstrated that centrosomal protein 131 (CEP131) exhibits oncogenic activity in osteosarcoma, hepatocellular carcinoma and breast cancer. The present study demonstrated that there is an association between CEP131 expression and advanced Tumor‑Node‑Metastasis stage (P=0.016), and positive regional lymph node metastasis (P=0.023) in 91 cases of non‑small cell lung cancer. A549 and SPC‑A‑1 cells, with moderate expression levels of CEP131, were selected as representative cell lines. The results indicated that downregulation of CEP131 induced G1/S cell cycle arrest, inhibition of cyclins D1/E and cyclin‑dependent kinases 2/4/6, and induction of inhibitory p21/p27, all of which are regulated by ERK and AKT signaling, suggesting that CEP131 exhibits potential as a novel target in the treatment of lung cancer.
View Figures
View References

Related Articles

Journal Cover

April-2020
Volume 19 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang J, Yang X, Han S and Zhang L: CEP131 knockdown inhibits cell proliferation by inhibiting the ERK and AKT signaling pathways in non‑small cell lung cancer. Oncol Lett 19: 3145-3152, 2020.
APA
Wang, J., Yang, X., Han, S., & Zhang, L. (2020). CEP131 knockdown inhibits cell proliferation by inhibiting the ERK and AKT signaling pathways in non‑small cell lung cancer. Oncology Letters, 19, 3145-3152. https://doi.org/10.3892/ol.2020.11411
MLA
Wang, J., Yang, X., Han, S., Zhang, L."CEP131 knockdown inhibits cell proliferation by inhibiting the ERK and AKT signaling pathways in non‑small cell lung cancer". Oncology Letters 19.4 (2020): 3145-3152.
Chicago
Wang, J., Yang, X., Han, S., Zhang, L."CEP131 knockdown inhibits cell proliferation by inhibiting the ERK and AKT signaling pathways in non‑small cell lung cancer". Oncology Letters 19, no. 4 (2020): 3145-3152. https://doi.org/10.3892/ol.2020.11411